PMID- 23086447 OWN - NLM STAT- MEDLINE DCOM- 20130117 LR - 20220408 IS - 1529-2916 (Electronic) IS - 1529-2908 (Print) IS - 1529-2908 (Linking) VI - 13 IP - 12 DP - 2012 Dec TI - Control of RelB during dendritic cell activation integrates canonical and noncanonical NF-kappaB pathways. PG - 1162-70 LID - 10.1038/ni.2446 [doi] AB - The NF-kappaB protein RelB controls dendritic cell (DC) maturation and may be targeted therapeutically to manipulate T cell responses in disease. Here we report that RelB promoted DC activation not as the expected RelB-p52 effector of the noncanonical NF-kappaB pathway, but as a RelB-p50 dimer regulated by canonical IkappaBs, IkappaBalpha and IkappaBvarepsilon. IkappaB control of RelB minimized spontaneous maturation but enabled rapid pathogen-responsive maturation. Computational modeling of the NF-kappaB signaling module identified control points of this unexpected cell type-specific regulation. Fibroblasts that we engineered accordingly showed DC-like RelB control. Canonical pathway control of RelB regulated pathogen-responsive gene expression programs. This work illustrates the potential utility of systems analyses in guiding the development of combination therapeutics for modulating DC-dependent T cell responses. FAU - Shih, Vincent F-S AU - Shih VF AD - Signaling Systems Laboratory, Department of Chemistry and Biochemistry and San Diego Center for Systems Biology, University of California, San Diego, La Jolla, California, USA. FAU - Davis-Turak, Jeremy AU - Davis-Turak J FAU - Macal, Monica AU - Macal M FAU - Huang, Jenny Q AU - Huang JQ FAU - Ponomarenko, Julia AU - Ponomarenko J FAU - Kearns, Jeffrey D AU - Kearns JD FAU - Yu, Tony AU - Yu T FAU - Fagerlund, Riku AU - Fagerlund R FAU - Asagiri, Masataka AU - Asagiri M FAU - Zuniga, Elina I AU - Zuniga EI FAU - Hoffmann, Alexander AU - Hoffmann A LA - eng SI - GEO/GSE34990 GR - GM071573/GM/NIGMS NIH HHS/United States GR - GM085325/GM/NIGMS NIH HHS/United States GR - P01 GM071862/GM/NIGMS NIH HHS/United States GR - AI090935/AI/NIAID NIH HHS/United States GR - AI081923/AI/NIAID NIH HHS/United States GR - R01 AI083453/AI/NIAID NIH HHS/United States GR - R01 AI081923/AI/NIAID NIH HHS/United States GR - P50 GM085764/GM/NIGMS NIH HHS/United States GR - R01 GM071573/GM/NIGMS NIH HHS/United States GR - R01 GM085325/GM/NIGMS NIH HHS/United States GR - GM085763/GM/NIGMS NIH HHS/United States GR - P01 AI090935/AI/NIAID NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural DEP - 20121021 PL - United States TA - Nat Immunol JT - Nature immunology JID - 100941354 RN - 0 (NF-kappa B) RN - 0 (Relb protein, mouse) RN - 0 (Tlr2 protein, mouse) RN - 0 (Tlr4 protein, mouse) RN - 0 (Tlr9 protein, mouse) RN - 0 (Toll-Like Receptor 2) RN - 0 (Toll-Like Receptor 4) RN - 0 (Toll-Like Receptor 9) RN - 147337-75-5 (Transcription Factor RelB) RN - EC 2.7.11.10 (I-kappa B Kinase) SB - IM CIN - Nat Immunol. 2012 Dec;13(12):1139-41. PMID: 23160209 MH - Animals MH - Cell Differentiation/genetics MH - Cell Line MH - Dendritic Cells/*immunology/*metabolism MH - Fibroblasts/metabolism MH - Gene Expression Regulation MH - I-kappa B Kinase/metabolism MH - *Lymphocyte Activation MH - Mice MH - Mice, Inbred C57BL MH - Mice, Knockout MH - NF-kappa B/genetics/*metabolism MH - Protein Multimerization MH - Signal Transduction MH - Toll-Like Receptor 2/metabolism MH - Toll-Like Receptor 4/metabolism MH - Toll-Like Receptor 9/metabolism MH - Transcription Factor RelB/genetics/*metabolism PMC - PMC3634611 MID - NIHMS404259 EDAT- 2012/10/23 06:00 MHDA- 2013/01/18 06:00 PMCR- 2013/06/01 CRDT- 2012/10/23 06:00 PHST- 2011/11/28 00:00 [received] PHST- 2012/08/29 00:00 [accepted] PHST- 2012/10/23 06:00 [entrez] PHST- 2012/10/23 06:00 [pubmed] PHST- 2013/01/18 06:00 [medline] PHST- 2013/06/01 00:00 [pmc-release] AID - ni.2446 [pii] AID - 10.1038/ni.2446 [doi] PST - ppublish SO - Nat Immunol. 2012 Dec;13(12):1162-70. doi: 10.1038/ni.2446. Epub 2012 Oct 21.